0001171843-18-000444.txt : 20180118
0001171843-18-000444.hdr.sgml : 20180118
20180118171759
ACCESSION NUMBER: 0001171843-18-000444
CONFORMED SUBMISSION TYPE: 4
PUBLIC DOCUMENT COUNT: 1
CONFORMED PERIOD OF REPORT: 20180117
FILED AS OF DATE: 20180118
DATE AS OF CHANGE: 20180118
REPORTING-OWNER:
OWNER DATA:
COMPANY CONFORMED NAME: Toner E. Scott
CENTRAL INDEX KEY: 0001643772
FILING VALUES:
FORM TYPE: 4
SEC ACT: 1934 Act
SEC FILE NUMBER: 001-36694
FILM NUMBER: 18534738
MAIL ADDRESS:
STREET 1: 25 PIER 7
CITY: CHARLESTOWN
STATE: MA
ZIP: 02129
ISSUER:
COMPANY DATA:
COMPANY CONFORMED NAME: PROTEON THERAPEUTICS INC
CENTRAL INDEX KEY: 0001359931
STANDARD INDUSTRIAL CLASSIFICATION: BIOLOGICAL PRODUCTS (NO DIAGNOSTIC SUBSTANCES) [2836]
IRS NUMBER: 000000000
STATE OF INCORPORATION: DE
FISCAL YEAR END: 1231
BUSINESS ADDRESS:
STREET 1: 200 WEST STREET
CITY: WALTHAM
STATE: MA
ZIP: 02451
BUSINESS PHONE: 781-890-0102
MAIL ADDRESS:
STREET 1: 200 WEST STREET
CITY: WALTHAM
STATE: MA
ZIP: 02451
4
1
formfour.xml
OWNERSHIP DOCUMENT
X0306
4
2018-01-17
0
0001359931
PROTEON THERAPEUTICS INC
PRTO
0001643772
Toner E. Scott
C/O PROTEON THERAPEUTICS
200 WEST STREET
WALTHAM
MA
02451
0
1
0
0
Senior VP of Commercial
Stock Option (Right to Buy)
2.85
2018-01-17
4
A
0
110000
0
A
2028-01-16
Common Stock, $0.001 par value
110000
110000
D
The options were granted on January 17, 2018 and the shares underlying this option vest 25% on the first anniversary of the grant date and the remaining shares vest in twelve equal quarterly installments.
/s/ George A. Eldridge as attorney-in-fact
2018-01-18